These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 16155724)
1. Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas. Wu AH; Xiao J; Anker L; Hall WA; Gregerson DS; Cavenee WK; Chen W; Low WC J Neurooncol; 2006 Jan; 76(1):23-30. PubMed ID: 16155724 [TBL] [Abstract][Full Text] [Related]
2. Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy. Ueda R; Ohkusu-Tsukada K; Fusaki N; Soeda A; Kawase T; Kawakami Y; Toda M Int J Cancer; 2010 Feb; 126(4):919-29. PubMed ID: 19728337 [TBL] [Abstract][Full Text] [Related]
3. Combination epidermal growth factor receptor variant III peptide-pulsed dendritic cell vaccine with miR-326 results in enhanced killing on EGFRvIII-positive cells. Li J; Wang F; Wang G; Sun Y; Cai J; Liu X; Zhang J; Lu X; Li Y; Chen M; Chen L; Jiang C Oncotarget; 2017 Apr; 8(16):26256-26268. PubMed ID: 28412740 [TBL] [Abstract][Full Text] [Related]
4. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma. Yamanaka R; Honma J; Tsuchiya N; Yajima N; Kobayashi T; Tanaka R J Neurooncol; 2005 Apr; 72(2):107-13. PubMed ID: 15925989 [TBL] [Abstract][Full Text] [Related]
5. Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model. Wang X; Zhang FC; Zhao HY; Lu XL; Sun Y; Xiong ZY; Jiang XB Tumour Biol; 2014 Aug; 35(8):7781-91. PubMed ID: 24816916 [TBL] [Abstract][Full Text] [Related]
6. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11. Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861 [TBL] [Abstract][Full Text] [Related]
7. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028 [TBL] [Abstract][Full Text] [Related]
8. Identification of a naturally processed HLA-A*0201 HPV18 E7 T cell epitope by tumor cell mediated in vitro vaccination. Kather A; Ferrara A; Nonn M; Schinz M; Nieland J; Schneider A; Dürst M; Kaufmann AM Int J Cancer; 2003 Apr; 104(3):345-53. PubMed ID: 12569558 [TBL] [Abstract][Full Text] [Related]
9. Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy. Wu J; Wei J; Meng K; Chen J; Gao W; Zhang J; Xu Z; Miao Y Immunopharmacol Immunotoxicol; 2009; 31(3):468-76. PubMed ID: 19555216 [TBL] [Abstract][Full Text] [Related]
10. Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis. Schmidt SM; Schag K; Müller MR; Weinschenk T; Appel S; Schoor O; Weck MM; Grünebach F; Kanz L; Stevanovic S; Rammensee HG; Brossart P Cancer Res; 2004 Feb; 64(3):1164-70. PubMed ID: 14871853 [TBL] [Abstract][Full Text] [Related]
11. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Yu JS; Liu G; Ying H; Yong WH; Black KL; Wheeler CJ Cancer Res; 2004 Jul; 64(14):4973-9. PubMed ID: 15256471 [TBL] [Abstract][Full Text] [Related]
12. Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma. Kobayashi T; Yamanaka R; Homma J; Tsuchiya N; Yajima N; Yoshida S; Tanaka R Cancer Immunol Immunother; 2003 Oct; 52(10):632-7. PubMed ID: 12827308 [TBL] [Abstract][Full Text] [Related]
13. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme. Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247 [TBL] [Abstract][Full Text] [Related]
14. Branched multipeptide immunotherapy for glioblastoma using human leukocyte antigen-A*0201-restricted cytotoxic T-lymphocyte epitopes from ERBB2, BIRC5 and CD99. Kim YH; Tran TA; Lee HJ; Jung SI; Lee JJ; Jang WY; Moon KS; Kim IY; Jung S; Jung TY Oncotarget; 2016 Aug; 7(31):50535-50547. PubMed ID: 27409668 [TBL] [Abstract][Full Text] [Related]
15. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612 [TBL] [Abstract][Full Text] [Related]
16. Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain. Okano F; Storkus WJ; Chambers WH; Pollack IF; Okada H Clin Cancer Res; 2002 Sep; 8(9):2851-5. PubMed ID: 12231526 [TBL] [Abstract][Full Text] [Related]
17. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2. Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494 [TBL] [Abstract][Full Text] [Related]
18. Tumor antigen-specific T cells for immune monitoring of dendritic cell-treated glioblastoma patients. Müller I; Altherr D; Eyrich M; Flesch B; Friedmann KS; Ketter R; Oertel J; Schwarz EC; Technau A; Urbschat S; Eichler H Cytotherapy; 2016 Sep; 18(9):1146-61. PubMed ID: 27424145 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice. Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226 [TBL] [Abstract][Full Text] [Related]
20. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model. Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]